Lindsi Gordon, PA
Physician Assistant · Idaho Falls, IDNPI 1689194706
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Telix Pharmaceuticals at 27.5% of the total. Among physician assistant clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $55.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Telix Pharmaceuticals$2K
- Axonics, Inc.$2K
- Teleflex LLC$1K
- AbbVie$514
- Astellas Pharma US Inc$356
- Calyxo, Inc.$274
- plus $2K from 29 others
What the payments were for
- Travel & lodging$4,15848%
- Food & beverage$4,24349%
- Education$1802%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Telix Pharmaceuticals | 6 | $2,362 |
| Axonics, Inc. | 16 | $2,087 |
| Teleflex LLC | 15 | $1,340 |
| AbbVie(2 entities) | 24 | $514 |
| Astellas Pharma US Inc | 18 | $356 |
| Calyxo, Inc. | 2 | $274 |
| Johnson & Johnson | 7 | $183 |
| Procept Biorobotics Corporation | 3 | $180 |
| Boston Scientific | 5 | $146 |
| Sumitomo Pharma America, Inc. | 6 | $134 |
| Medtronic | 2 | $108 |
| Antares Pharma, Inc. | 6 | $98 |
| Endo Pharmaceuticals Inc. | 5 | $77 |
| Pfizer | 4 | $76 |
| Laborie Medical Technologies Corp. | 3 | $68 |
| Urovant Sciences Inc | 3 | $65 |
| Immunitybio, Inc. | 3 | $64 |
| Coloplast | 3 | $49 |
| Myovant Sciences Inc. | 3 | $45 |
| Dendreon Pharmaceuticals LLC | 2 | $43 |
| Verity Pharmaceuticals Inc. | 2 | $38 |
| 180 Medical, Inc. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Convatec Inc. | 1 | $25 |
| Olympus America Inc. | 1 | $25 |
| Endo USA, Inc. | 1 | $21 |
| Ambu Inc. | 2 | $19 |
| Palette Life Sciences, Inc. | 1 | $19 |
| Bayer | 1 | $19 |
| Merck | 1 | $17 |
| Tolmar, Inc. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Urogen Pharma, Inc. | 1 | $14 |
| Myriad Genetic Laboratories, Inc. | 1 | $14 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILLUCCIX$2,283
- Axonics$1,736
- UroLift$1,163
- CVAC Aspiration System$274
- AquaBeam Robotic System$149
How this compares
$8,581 in reported general payments places this provider in the 95th percentile of 1,027 physician assistant providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 198 | $110,694 |
| GemtesaVibegron | 78 | $48,471 |
| ElmironPentosan Polysulfate Sodium | 18 | $14,868 |
| Solifenacin Succinate | 77 | $14,391 |
| Potassium Citrate ErPotassium Citrate | 63 | $9,214 |
| Tolterodine Tartrate ErTolterodine Tartrate | 33 | $7,986 |
| Trospium Chloride | 66 | $7,877 |
| Desmopressin Acetate | 51 | $6,215 |
| Oxybutynin Chloride ErOxybutynin Chloride | 99 | $3,353 |
| Tamsulosin Hcl | 310 | $3,098 |
| Methenamine Hippurate | 32 | $2,674 |
| Estradiol | 22 | $2,624 |
| Cephalexin | 182 | $1,867 |
| NitrofurantoinNitrofurantoin Macrocrystal | 51 | $1,808 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 143 | $1,668 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $356 | $110,694198 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $134 | $48,47178 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,027 physician assistant providers in Idaho.
Other physician assistant in Idaho Falls
- Tyler PondIdaho Falls$13K
- Jed WillardsonIdaho Falls$12K
- Joshua KillpackIdaho Falls$11K
- Phillip MarloweIdaho Falls$10K
- Tyson ParkerIdaho Falls$10K
- Rebecca NewbyIdaho Falls$9K
- Todd CranorIdaho Falls$9K
- Amanda ColemanIdaho Falls$7K
- Alan AdamsIdaho Falls$7K
- Melissa BatesIdaho Falls$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.